Life Sciences 4.0: Securing value through data-driven platforms

In Life Sciences 4.0: Securing value through data-driven platforms, EY’s latest edition of their Progressions series, they explore how health is being reimagined as a result of scientific and technological change and rising customer expectations. They also examine the ramifications for life sciences companies’ market offerings, business models and the new capabilities needed as the disciplines of health care and technology merge to become “health technology.”

Read the issue